Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$35.11
At close: May 9, 4:00 PM EDT
$35.11
0.000.00%
Pre-Market: May 9, 4:00 PM EDT
Comments
Loading...
Ultragenyx Pharmaceutical Stock Price, Quotes and Forecasts
RARENASDAQ
Ultragenyx Pharmaceutical (RARE) Forecast
NewsEarningsUltragenyx Pharmaceutical (RARE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Ultragenyx Pharmaceutical Stock Price, Quotes and Forecasts | NASDAQ:RARE | Benzinga
Explore Ultragenyx Pharmaceutical stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RARE.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ultragenyx Pharmaceutical (RARE) stock?
You can purchase shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) through any online brokerage.
Who are Ultragenyx Pharmaceutical (RARE) competitors?
Other companies in Ultragenyx Pharmaceutical’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Sarepta Therapeutics (NASDAQ:SRPT), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
What is the forecast, or price target, for Ultragenyx Pharmaceutical (RARE) stock?
Ultragenyx Pharmaceutical has a consensus price target of $93.91.
What is the current price for Ultragenyx Pharmaceutical (RARE)?
The stock price for Ultragenyx Pharmaceutical (NASDAQ: RARE) is $35.11 last updated May 9, 2025 at 4:00 PM EDT.
Does Ultragenyx Pharmaceutical (RARE) pay a dividend?
There are no upcoming dividends for Ultragenyx Pharmaceutical.
When is Ultragenyx Pharmaceutical (NASDAQ:RARE) reporting earnings?
Ultragenyx Pharmaceutical’s Q2 earnings are confirmed for Thursday, July 31, 2025.
Is Ultragenyx Pharmaceutical (RARE) going to split?
There is no upcoming split for Ultragenyx Pharmaceutical.
What sector and industry does Ultragenyx Pharmaceutical (RARE) operate in?
Ultragenyx Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
